Cutler Group LLC / CA - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6
-99.9%
7100.0%0.00%
Q3 2022$5,000
-64.3%
710
-58.5%
0.00%
-100.0%
Q2 2022$14,000
+1300.0%
1,710
-78.6%
0.00%
Q1 2022$1,000
-95.5%
8,000
-37.6%
0.00%
-100.0%
Q4 2021$22,000
-51.1%
12,830
+8.3%
0.00%
-50.0%
Q3 2021$45,000
+462.5%
11,845
+11.7%
0.00%
Q2 2021$8,000
-88.1%
10,600
+51.4%
0.00%
-100.0%
Q2 2020$67,000
-5.6%
7,0000.0%0.00%0.0%
Q1 2020$71,000
+688.9%
7,000
+779.4%
0.00%
+300.0%
Q4 2019$9,000
-60.9%
796
-46.8%
0.00%
-50.0%
Q3 2019$23,000
-61.7%
1,496
-94.8%
0.00%
-60.0%
Q2 2019$60,000
+252.9%
28,996
+2545.6%
0.01%
+150.0%
Q1 2019$17,000
+240.0%
1,096
-52.3%
0.00%
Q4 2018$5,000
-89.6%
2,296
-89.4%
0.00%
-100.0%
Q3 2018$48,000
+14.3%
21,596
-14.3%
0.00%0.0%
Q2 2018$42,000
-17.6%
25,196
+255.1%
0.00%
-40.0%
Q1 2018$51,000
-8.9%
7,096
-53.3%
0.01%
+150.0%
Q4 2017$56,000
-18.8%
15,200
-61.8%
0.00%
-33.3%
Q3 2017$69,000
-87.2%
39,800
-79.2%
0.00%
-85.0%
Q2 2017$541,000
-8.5%
191,073
+9.5%
0.02%
-20.0%
Q1 2017$591,000
+50.4%
174,500
+72.9%
0.02%
+78.6%
Q4 2016$393,000
+182.7%
100,923
+10.8%
0.01%
+133.3%
Q3 2016$139,000
+396.4%
91,100
+503.3%
0.01%
+500.0%
Q2 2016$28,000
-28.2%
15,100
+22.8%
0.00%
-50.0%
Q1 2016$39,000
-26.4%
12,300
+64.0%
0.00%0.0%
Q4 2015$53,0007,5000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders